Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.67)
# 805
Out of 5,113 analysts
140
Total ratings
55.56%
Success rate
5.14%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $415 → $385 | $293.08 | +31.36% | 18 | Jan 28, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $500 → $540 | $484.52 | +11.45% | 13 | Jan 28, 2026 | |
| EHAB Enhabit | Upgrades: Outperform | $14 | $10.26 | +36.45% | 3 | Jan 22, 2026 | |
| EVH Evolent Health | Maintains: Outperform | $18 → $12 | $3.38 | +255.03% | 1 | Nov 12, 2025 | |
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $29.70 | +1.03% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $431.82 | +34.32% | 13 | Jul 31, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $41.29 | +4.14% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $196.59 | +57.69% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $271.25 | +38.25% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $5.85 | +105.13% | 11 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $37 | $27.62 | +33.99% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $170.24 | -1.32% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $104.46 | +38.81% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $34.11 | +17.28% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.03 | +65.02% | 10 | Jul 25, 2024 |
UnitedHealth Group
Jan 28, 2026
Maintains: Outperform
Price Target: $415 → $385
Current: $293.08
Upside: +31.36%
HCA Healthcare
Jan 28, 2026
Maintains: Outperform
Price Target: $500 → $540
Current: $484.52
Upside: +11.45%
Enhabit
Jan 22, 2026
Upgrades: Outperform
Price Target: $14
Current: $10.26
Upside: +36.45%
Evolent Health
Nov 12, 2025
Maintains: Outperform
Price Target: $18 → $12
Current: $3.38
Upside: +255.03%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $29.70
Upside: +1.03%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $431.82
Upside: +34.32%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $41.29
Upside: +4.14%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $196.59
Upside: +57.69%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $271.25
Upside: +38.25%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $5.85
Upside: +105.13%
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $27.62
Upside: +33.99%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $170.24
Upside: -1.32%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $104.46
Upside: +38.81%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $34.11
Upside: +17.28%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.03
Upside: +65.02%